remifentanil "teva" 5 mg pulver til koncentrat til injektions-/infusionsvæske, opløsning
teva b.v. - remifentanilhydrochlorid - pulver til koncentrat til injektions-/infusionsvæske, opløsning - 5 mg
hemlibra
roche registration limited - emicizumab - hemophilia a - antihemorrhagics - hemlibra is indicated for routine prophylaxis of bleeding episodes in patients with haemophilia a (congenital factor viii deficiency):with factor viii inhibitorswithout factor viii inhibitors who have:severe disease (fviii < 1%)moderate disease (fviii ≥ 1% and ≤ 5%) with severe bleeding phenotype. hemlibra kan bruges i alle aldersgrupper.
remifentanil "orion" 1 mg pulver til koncentrat til injektions-/infusionsvæske, opløsning
orion corporation - remifentanilhydrochlorid - pulver til koncentrat til injektions-/infusionsvæske, opløsning - 1 mg
buprenorphin "actavis" 2 mg resoribletter, sublinguale
actavis group ptc ehf. - buprenorphinhydrochlorid - resoribletter, sublinguale - 2 mg
buprenorphin "actavis" 8 mg resoribletter, sublinguale
actavis group ptc ehf. - buprenorphinhydrochlorid - resoribletter, sublinguale - 8 mg
buprenorphine "bluefish" 0,4 mg resoribletter, sublinguale
bluefish pharmaceuticals ab - buprenorphinhydrochlorid - resoribletter, sublinguale - 0,4 mg
buprenorphine "bluefish" 8 mg resoribletter, sublinguale
bluefish pharmaceuticals ab - buprenorphinhydrochlorid - resoribletter, sublinguale - 8 mg
buprenorphine "ethypharm" 0,4 mg resoribletter, sublinguale
ethypharm - buprenorphinhydrochlorid - resoribletter, sublinguale - 0,4 mg
buprenorphine "ethypharm" 2 mg resoribletter, sublinguale
ethypharm - buprenorphinhydrochlorid - resoribletter, sublinguale - 2 mg
buprenorphine "ethypharm" 8 mg resoribletter, sublinguale
ethypharm - buprenorphinhydrochlorid - resoribletter, sublinguale - 8 mg